EC-3 INTRAOCULAR LENS (IOL) AND EC-3 PRECISION ASPHERIC LENS (PAL) IOL
Carl Zeiss Meditec Production, LLC · Decision date Oct 19, 2010
What did the FDA approve?
The FDA database entry records an original PMA approval for the EC-3 Intraocular Lens (IOL) and EC-3 Precision Aspheric Lens (PAL) IOL, decided on October 19, 2010. The applicant is Carl Zeiss Meditec Production, LLC, and the product code is HQL under the Ophthalmic specialty.
The stated indication is primary implantation in the capsular bag of the eye for visual correction of aphakia in adult patients after cataractous lens removal. The source statement reports this intended purpose but does not itself provide independent proof of safety or clinical effectiveness. No supplement type or supplement reason is listed, so no additional change to an earlier approval is described.
FDA approval order statement
APPROVAL FOR THE EC-3 INTRAOCULAR LENS (IOL) AND EC-3 PRECISION ASPHERIC LENS (PAL) IOL. THE DEVICE IS INDICATED FOR PRIMARY IMPLANTATION IN THE CAPSULAR BAG OF THE EYE FOR THE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS IN WHOM A CATARACTOUS LENS HAS BEEN REMOVED.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 19, 2010
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100016
- Regulatory pathway
- Premarket approval application
- Applicant
- Carl Zeiss Meditec Production, LLC
- Product code
- HQL
- Decision code
- APPR
- Decision date
- Oct 19, 2010
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Applicant
- Carl Zeiss Meditec Production, LLC
- Product code
- HQL
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P100016 received
Application receipt date recorded by FDA.
P100016 · FDA decision
APPR
P100016/S028 · Related supplement
CT LUCIA Intraocular Lenses (IOLs)
Timeline entries are records held by MedtechLedger for P100016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Carl Zeiss Meditec Production, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1040 S. Vintage Ave., Bldg. A, Ontario, CA, 91761
Sources and methodology
- Original FDA record: P100016
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




